每周股票复盘：维力医疗（603309）控股子公司获医疗器械经营许可证

Core Points - Vili Medical's stock price increased by 1.07% to 12.28 yuan as of May 23, 2025, with a market capitalization of 3.596 billion yuan [1] - The company announced the acquisition of a Class III medical device operating license for its subsidiary, which will not significantly impact its financial performance [1] - Vili Medical plans to establish a subsidiary in Indonesia with a total investment of 500 billion Indonesian rupiah, with the company holding 95% of the shares [1] - The company declared a cash dividend of 0.5 yuan per share, totaling 146.43 million yuan, with the ex-dividend date set for May 29, 2025 [2] - Vili Medical's product, the Extraction Bag, received certification from Health Canada, allowing it to be sold legally in the Canadian market [2] Company Announcements - Vili Medical's subsidiary obtained a Class III medical device operating license [3] - Vili Medical's product received certification from Health Canada [3] - Vili Medical announced the establishment of a subsidiary in Indonesia [3] - Vili Medical implemented its 2024 annual equity distribution plan [3]